Filing Details

Accession Number:
0001209191-20-057719
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-10 17:43:09
Reporting Period:
2020-11-09
Accepted Time:
2020-11-10 17:43:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662411 Warren James Huff 5320 Legacy Drive
Plano TX 75024
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2020-11-09 16,687 $175.06 64,970 No 4 S Direct
Class A Common Stock Disposition 2020-11-10 64,970 $175.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 12,500 Indirect By The 2019 JWH GRAT
Class A Common Stock 12,500 Indirect By The 2019 WBH GRAT
Class A Common Stock 1,583 Indirect By Huff 2010 Descendants' Trust FBO Connor Huff
Class A Common Stock 1,583 Indirect By Huff 2010 Descendants' Trust FBO Dillon Huff
Footnotes
  1. The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $175.00 to $175.30. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $175.00 to $175.13. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. Includes shares of Class A common stock previously held directly by the Reporting Person, which were transferred to The 2019 JWH GRAT.
  5. Includes shares of Class A common stock previously held by the Reporting Person's spouse, which were transferred to The 2019 WBH GRAT.
  6. Includes shares of Class A common stock previously held by the Huff 2010 Descendants' Trust, which were distributed to the Huff 2010 Descendants' Trust FBO Connor Huff and the Huff 2010 Descendants' Trust FBO Dillon Huff.